Molecular Pathology

Bringing the innovation of molecular genetic testing to enhance patient care

Genetic testing involves the analysis of DNA in order to detect genetic variations related to an individual’s health.

The information from such tests can be used in multiple areas of patient care, including routine health assessments (STI/WH), disease risk assessments (ICGx), and optimization of drug treatments (PGx). Our lab utilizes state-of-the-art instrumentation and genetic assays that are extensively validated in-house and performed by highly trained and qualified staff. We understand that molecular pathology is an emerging field, so please don’t hesitate to reach out with any questions you may have.

With a Molecular Pathology test, health care professionals can practice precision medicine by incorporating an individual’s genetic profile and other diagnostics to customize medical care.

Genetic Information Nondiscrimination Act of 2008

The Genetic Information Nondiscrimination Act of 2008 (GINA) makes it illegal for health insurers to request or use one’s genetic information to deny health insurance, or to alter how much one pays for health insurance. This also means that your genetic information cannot be used to determine if a condition is considered pre-existing. GINA also protects individuals from genetic discrimination by employers.

GINA does not apply to life, long-term care, or disability insurance. Therefore, you may be asked to disclose your genetic information when applying for these types of insurances, depending on your state of residence. Different states have extended protection to cover other forms of insurance.

More information about GINA can be found on GINAhelp.org or through your state insurance commissioner’s office.

View List of PGx Genes

Pharmacogenomics (PGx)

  • Analyzes a patient’s genetic make-up to optimize drug selection and dosing.
  • A one-time test used to provide precision guidance for medications used in managing cardiovascular, mental disorders, pain, cancer treatment, diabetes, gastrointestinal conditions, infectious disease, immune disorders, and urological conditions.

STI Testing & Women’s Health

  • STI testing is available for women and men, as part of routine care or when an STI is suspected. This test detects the DNA of several microorganims and viral infections which cause STIs.
  • The Women’s Health test can be used to detect the DNA of microorganisms that contribute to vaginal dysbiosis syndromes, and as part of routine care to monitor a women’s vaginal microbiome.

Inherited Cancer Genetics (ICGx)

  • Next generation sequencing technology is used to screen for pathogenic genetic variants which may predispose individuals to a higher risk of developing certain kinds of cancer.
  • Used when a strong family history of cancer is indicated, as part of preventative screening.